Inhibition of cancer cell growth by ruthenium complexes

Joji Iida, Elisabeth T. Bell-Loncella, Marc L. Purazo, Yifeng Lu, Jesse Dorchak, Rebecca Clancy, Julianna Slavik, Mary Lou Cutler, Craig D. Shriver

Research output: Contribution to journalArticle

Abstract

Background: Previous studies suggest that certain transition metal complexes, such as cisplatin, are efficacious for treating various cancer types, including ovarian, lung, and breast. Methods: In order to further evaluate ruthenium (Ru) complexes as potential anti-cancer agents, we synthesized and evaluated Ru-arene complexes. Two complexes with the general formula [Ru (n 6-p-cym) (N-N) Cl]+ were tested for their abilities to inhibit cancer cells. Results: The complex with o-phenylenediamine as the N-N ligand (o-PDA) significantly inhibited growth of breast (MDA-MB-231, MCF-7, SKBR-3, and SUM149), lymphoma (Raji), melanoma (Bowes), and osteosarcoma (HT1080); however, the complex with o-benzoquinonediimine (o-BQDI) was ineffective except for SUM149. In contrast, o-PDA failed to inhibit growth of human breast epithelial cells, MCF-10A. Treatment of MDA-MBA-231 cells with o-PDA resulted in a significant reduction of productions of PDGF-AA, GM-CSF, and VEGF-A proteins at the transcriptional levels. Finally, we demonstrated that o-PDA synergistically inhibited MDA-MB-231 cell growth with cyclophosphamide but not doxorubicin or paclitaxel. Conclusion: These results suggest that Ru-arene complexes are promising anti-cancer drugs that inhibit progression and metastasis by blocking multiple processes for breast and other types of cancer.

Original languageEnglish (US)
Article number48
JournalJournal of translational medicine
Volume14
Issue number1
DOIs
StatePublished - Feb 12 2016

Keywords

  • Anti-cancer reagents
  • Breast cancer
  • GM-CSF
  • Growth
  • PDGF
  • Ruthenium
  • Synergy
  • VFGF

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Inhibition of cancer cell growth by ruthenium complexes'. Together they form a unique fingerprint.

  • Cite this

    Iida, J., Bell-Loncella, E. T., Purazo, M. L., Lu, Y., Dorchak, J., Clancy, R., Slavik, J., Cutler, M. L., & Shriver, C. D. (2016). Inhibition of cancer cell growth by ruthenium complexes. Journal of translational medicine, 14(1), [48]. https://doi.org/10.1186/s12967-016-0797-9